Citadel Advisors
BMRA icon

Citadel Advisors’s Biomerica BMRA Stock Holding History

Citadel Advisors’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,423
Closed -$29.4K – 14281
2024
Q1 		$29.4K Buy
+4,423
New +$35.9K ﹤0.01% 12711
2023
Q3 		– Sell
-5,470
Closed -$59.5K – 14305
2023
Q2 		$59.5K Buy
5,470
+2,019
+59% +$23.9K ﹤0.01% 11603
2023
Q1 		$51.6K Sell
3,451
-2,339
-40% -$50.4K ﹤0.01% 12101
2022
Q4 		$155K Buy
5,790
+4,335
+298% +$125K ﹤0.01% 10564
2022
Q3 		$46K Sell
1,455
-227
-13% -$5.88K ﹤0.01% 11685
2022
Q2 		$39K Sell
1,682
-2,419
-59% -$69.1K ﹤0.01% 12073
2022
Q1 		$147K Buy
+4,101
New +$136K ﹤0.01% 11869
2021
Q3 		– Sell
-2,222
Closed -$73K – 13811
2021
Q2 		$71K Buy
+2,222
New +$75.3K ﹤0.01% 13152
2019
Q2 		– Sell
-1,406
Closed -$28K – 9176
2019
Q1 		$28K Buy
+1,406
New +$27.4K ﹤0.01% 9008

Other funds holding BMRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors's BMRA Position: Q2 2024 in Review

Citadel Advisors sold out of Biomerica (BMRA) in Q2 2024, closing a stake of 4,423 shares — an estimated $29.4K sold.

Citadel Advisors first reported a position in BMRA in Q1 2019 and held it in 9 quarters. The position peaked at $155K in Q4 2022. 35 funds tracked by Wall St. Rank hold BMRA as of Q2 2024.

  • Citadel Advisors reported no remaining Biomerica position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 4,423 Biomerica shares in Q2 2024, an estimated $29.4K.
  • Citadel Advisors first reported a position in Biomerica in Q1 2019 and held it in 9 quarters.
  • Citadel Advisors's Biomerica position peaked at $155K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Biomerica as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.